ALHC Stock Alignment Healthcare (ALHC, $15.69) entered Uptrend as Momentum indicator ascends above 0 level on Feb 28, 2025

GET DAILY SIGNALS

Get AI intraday signals

ALHC - Alignment Healthcare

Momentum signal

View

Odds of UP Trend

Price: $15.69

Daily change: +$2.22 (+16.48%)

Daily volume: 4.8M

Capitalization: $3B

Industry: Managed Health Care

ALHC in +4.59% Uptrend, advancing for three consecutive days on March 12, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ALHC advanced for three days, in of 239 cases, the price rose further within the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 28, 2025. You may want to consider a long position or call options on ALHC as a result. In of 64 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ALHC just turned positive on March 03, 2025. Looking at past instances where ALHC's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

ALHC moved above its 50-day moving average on February 27, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The 10-day RSI Indicator for ALHC moved out of overbought territory on February 06, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALHC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALHC broke above its upper Bollinger Band on February 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ALHC entered a downward trend on February 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ALHC's P/B Ratio (5.974) is slightly higher than the industry average of (3.063). ALHC's P/E Ratio (0.000) is considerably lower than the industry average of (17.509). ALHC's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.089). ALHC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (0.506) is also within normal values, averaging (0.684).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.